Synonym
DW34; DW-34; DW 34
IUPAC/Chemical Name
2-(4-(5-(6-(3,5-dimethylphenoxy)pyridin-2-yl)-4-methyl-1H-1,2,3-triazol-1-yl)piperidin-1-yl)-N,N-dimethylethan-1-amine
InChi Key
PIKWYDHWUKSWAQ-UHFFFAOYSA-N
InChi Code
InChI=1S/C25H34N6O/c1-18-15-19(2)17-22(16-18)32-24-8-6-7-23(26-24)25-20(3)27-28-31(25)21-9-11-30(12-10-21)14-13-29(4)5/h6-8,15-17,21H,9-14H2,1-5H3
SMILES Code
CC1=C(C2=CC=CC(OC3=CC(C)=CC(C)=C3)=N2)N(C4CCN(CCN(C)C)CC4)N=N1
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
434.59
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Cui H, Carlson AS, Schleiff MA, Divakaran A, Johnson JA, Buchholz CR, Zahid
H, Vail NR, Shi K, Aihara H, Harki DA, Miller GP, Topczewski JJ, Pomerantz WCK.
4-Methyl-1,2,3-Triazoles as N-Acetyl-Lysine Mimics Afford Potent BET
Bromodomain Inhibitors with Improved Selectivity. J Med Chem. 2021 Jul
22;64(14):10497-10511. doi: 10.1021/acs.jmedchem.1c00933. Epub 2021 Jul 8. PMID:
34236185; PMCID: PMC8491147.
2: Sekai M, Tani-ichi S, Yoneyama M, Fujita T, Kina T, Ikuta K. Lymphocyte-
stromal cell interaction induces IL-7 expression by interferon regulatory
factors. Mol Immunol. 2013 Jul;54(3-4):378-85. doi:
10.1016/j.molimm.2013.01.002. Epub 2013 Jan 30. PMID: 23376291.
3: Nagasawa T, Kikutani H, Kishimoto T. Molecular cloning and structure of a
pre-B-cell growth-stimulating factor. Proc Natl Acad Sci U S A. 1994 Mar
15;91(6):2305-9. doi: 10.1073/pnas.91.6.2305. PMID: 8134392; PMCID: PMC43359.
4: Nakayama T, Mutsuga N, Tosato G. Effect of fibroblast growth factor 2 on
stromal cell-derived factor 1 production by bone marrow stromal cells and
hematopoiesis. J Natl Cancer Inst. 2007 Feb 7;99(3):223-35. doi:
10.1093/jnci/djk031. PMID: 17284717.
5: Kaisho T, Oritani K, Ishikawa J, Tanabe M, Muraoka O, Ochi T, Hirano T. Human
bone marrow stromal cell lines from myeloma and rheumatoid arthritis that can
support murine pre-B cell growth. J Immunol. 1992 Dec 15;149(12):4088-95. PMID:
1281201.